2013
DOI: 10.1111/dsu.12301
|View full text |Cite
|
Sign up to set email alerts
|

A Review of the Metabolism of 1,4-Butanediol Diglycidyl Ether-Crosslinked Hyaluronic Acid Dermal Fillers

Abstract: BackgroundCosmetic procedures are growing ever more common, and the use of soft tissue fillers is increasing. Practicing physicians need to be aware of the biological behavior of these products in tissue to enable them to respond to any safety concerns that their patients raise.ObjectivesTo provide an overview of the metabolism of 1,4-butanediol diglycidyl ether (BDDE)-crosslinked hyaluronic acid (HA) dermal fillers and to examine the safety of the resulting byproducts.MethodsA review of available evidence was… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
175
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 214 publications
(202 citation statements)
references
References 22 publications
1
175
0
Order By: Relevance
“…12 Biocompatibility data provide some reassurance regarding long-term exposure to the cross-linker 4-butanedioldiglycidyl ether in some hyaluronic acid filler products. 13,14 …”
Section: Complication Management Is the Largest Unmet Need With Hyalumentioning
confidence: 99%
“…12 Biocompatibility data provide some reassurance regarding long-term exposure to the cross-linker 4-butanedioldiglycidyl ether in some hyaluronic acid filler products. 13,14 …”
Section: Complication Management Is the Largest Unmet Need With Hyalumentioning
confidence: 99%
“…The reaction between HA and BDDE was performed in strong alkaline conditions to form a stable covalent ether bond (De Boulle et al, 2013). At a very high pH range, the epoxide groups of BDDE preferentially react with the hydroxyl groups of HA, because the deprotonated hydroxyls are much stronger nucleophiles than both the anionic carboxylic group and the amide (Kenne et al, 2013).…”
Section: Accepted Manuscriptmentioning
confidence: 99%
“…Generally, scaffolds oen used for so tissue regeneration, such as polyglycolic acid (PGA) and collagen, are difficult to use for hard tissue engineering, whereas scaffolds such as b-tricalcium phosphate (b-TCP) and bioceramics, are mainly used for hard tissue regeneration, e.g. 28 Hence, BDDE-crosslinked HA gels (HAGs) in the form of microparticles are proposed to be used as an injectable scaffold to regenerate dentin-pulp complex in this work. 9,[12][13][14][15][16][17] Therefore, it is of great necessity to develop a suitable and injectable scaffold that can penetrate the entire root canal space 1,4,5,8,[18][19][20][21][22] and is also suitable for clinical application.…”
Section: Introductionmentioning
confidence: 99%